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Abstract
The use of opioids is associated with risks for misuse, abuse, addiction and diversion, which are
directly related to increased healthcare utilization, increased healthcare cost, and poor patient
outcomes. The purpose of this study was to evaluate the impact of controlled substance (CS)
patient education that was implemented into the electronic medical record. The objectives were
to 1.) assess whether patients received the CS after visit summary (AVS) and 2.) assess
differences in pain management knowledge between those who received the AVS and those who
did not. Methods This descriptive correlational designed study examined the differences in pain
management knowledge between those who did and did not receive the AVS. The study
included patients that received care and a prescription for a controlled substance at a primary
care office for management of chronic noncancerous pain. Knowledge of the patients’ pain
medication was measured via an anonymous written survey that was administered by the primary
care office front desk staff. Results A total of 317 patients met inclusion criteria and therefore
their names were given to the front desk staff to offer the survey. Thirty seven useable surveys
were returned. There was no significant knowledge difference between the two groups and over
all both groups were generally knowledgeable about controlled substances. Conclusion
Although there was no significant difference in knowledge between the two groups in this study,
the literature supports the use of written patient education. The addition of further controlled
substance education utilizing different avenues of media would compliment the AVS and be
helpful to increase patient knowledge.

1  
  

  

Evaluation of the Impact of Controlled Substance Patient Education in the After Visit
Summary on Patient Knowledge of Controlled Substance Medication
Introduction
The National Institutes of Health found an estimated 11.2% of adults suffer from pain
every day (2015). As a result, more than 249 million opioid prescriptions were written in 2013
(Centers for Disease Control [CDC], 2016). The use of opioids is associated with risks for
misuse, abuse, addiction and diversion (Hahn, K., 2011, SAMHSA, 2016). The abuse and misuse
is directly related to increased healthcare utilization, increased healthcare cost, and poor patient
outcomes (Hahn, K., 2011, SAMHSA, 2016). Patient education has proven to be an effective
intervention to increase safety for those prescribed chronic pain medications. The purpose of this
study is to evaluate the impact of controlled substance education in the after visit summary on
patient knowledge of controlled substance medication.
Background
In the United States, fatal opioid overdoses have increased at an alarming rate. Over
28,000 people died from an opioid overdose in 2014, and since 1999 the death rate from opioid
overdoses has more than quadrupled (CDC, 2016). The opioid epidemic has been especially
damaging in Kentucky, where the rate of opioid overdoses is almost double the national rate (see
figure 1.) (National Institute on Drug Abuse, 2018). From 1999 to 2008, Kentucky reported a
26% increase in its opioid overdose mortality, compared to a national increase of only 10%
(Kentucky State Epidemiology Outcomes Workgroup, 2011). The Council of Economic
Advisors (CEA) reports that the cost of the opioid crisis is grossly underestimated (2017). When
considering forgone earnings, criminal justice cost, increased healthcare utilization and lost
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productivity, the CEA reports a low estimate of 221 billion dollars spent on the opioid crisis in
2015 (2017).
Legislation has been written with the intent to address prescription drug abuse. In 2012,
House Bill 1 (HB1) was passed in Kentucky to create prescribing, dispensing and reporting
standards and to develop a mandate for licensing boards to institute regulations around
prescribing and dispensing controlled substances. HB1 required that prescribing providers
utilize the state prescription drug-monitor program, Kentucky All Schedule Prescription
Electronic Reporting (KASPER), to maintain prescribing awareness of patients’ prescription
controlled substance histories when making treatment decisions (Cabinet for Health and Family
Services, 2018).
Data derived in a post intervention evaluation of HB1 found an expected overall decrease
in narcotic prescribing by 4-8%, depending on specific drug, and a decrease in doctor shopping.
Doctor shopping is defined as filling four or more CS prescriptions at four or more different
pharmacies in a three-month period (Freeman, Goodin, Troske, & Talbert, 2015). However, an
unintended consequence of HB1 was an increase in Kentucky’s heroin overdoses and hospital
discharges related to heroin (Freeman et al., 2015). Additionally, the effect HB1 has on patients
with a legitimate medical necessity for CS’s needs to be taken into consideration. There is
qualitative evidence that some providers chose to completely stop prescribing controlled
substances after HB1 was passed, thus affecting patients’ pain management (Freeman et al.,
2015). Other analyses argue patients with a medical necessity for CS have been unaffected
(Freeman, et al, 2015). Even after implementation of HB1, controlled substance abuse and
misuse continues to be a problem.
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In 2016, the CDC responded to the opioid epidemic and lack of provider prescribing
knowledge by publishing a guideline to ensure safe prescribing practices. The CDC (2016)
Guideline for Prescribing Opioids for Chronic Pain recommends that providers discuss with
patients the risks and benefits of therapy at the start and periodically during opioid treatment as a
category A (strong evidence) recommendation. Additionally, the guideline addresses when to
initiate and/or continue opioids, goals of treatment, alternate therapies, follow up, monitoring
requirements, how to assess risks, and additional documentation that is needed when prescribing
(CDC, 2016).
In response to the opioid epidemic in Kentucky and an increase in state and federal
legislation, a Louisville area healthcare system acknowledged their responsibility to patients and
the community by developing a multidisciplinary task force to evaluate the issue within their
healthcare system. The group established a mission to guarantee appropriate, responsible and
judicious prescribing of controlled substances to ensure patient safety and compliance with state
and federal regulations. The task force works to achieve this mission by meeting the following
goals: implementing system process changes, providing education and feedback via audits, giving
lectures and communicating with providers about prescribing CS, implementing drug take backs,
optimizing technology within care delivery and educating patients. The efforts of the group are
evaluated at a monthly meeting. Overall the task force has seen a downward trend in the number
of controlled substances prescribed by the healthcare system, which is especially significant due
to a steady increase in the number of practicing providers.
The healthcare system had taken steps to educate providers about the CDC guideline and
evaluate the systems prescribing trends, but had not provided educational resources for patients.
Recognizing this gap, the task force utilized the 2016 CDC Guideline for Prescribing Opioids for
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Chronic Pain to implement patient educational resources on controlled substances into the
electronic medical record (EMR). The patient education was devised from the 2016 CDC
guideline and peer reviewed by the task force, medical directors, and a literacy specialist within
the system to ensure the content was complete and at a fifth grade reading level. Beginning in
February of 2018, the CS patient education was attached to all patients’ after visit summary
(AVS) every time an opioid was prescribed. The AVS included safety highlights from the CDC
guideline. Building CS discharge information into the EMR is a helpful way to reinforce the
CDC guidelines regarding provider/patient discussion of therapy risk and benefits, side effects,
and safe storage and disposal.
Addressing the issue of increasing opioid addiction and overdose begins with providing
clear patient education about CS at the time the prescription is issued (Hahn, 2011; McCarthy et
al., 2015; Hero, McMurtry, Benson, & Blendon, 2016; CDC, 2016). Written education has
proven to be successful in increasing knowledge in safety areas such as driving and
storage/disposal of medications (McCarthy et al., 2015; Rose et al., 2015). Patient education can
influence a patient’s decision to operate a motor vehicle while taking CS, decrease misuse
behaviors, increase knowledge of safe use, storage and disposal and result in positive behavioral
consequences (Rose, Sakai, Argue, Froehlich, & Tay, 2015; McCauley, Back, & Brady, 2013;
McCarthy et al., 2015; Hero et al., 2016).
It is difficult to measure the potential effect of increased patient knowledge and safe CS
usage because the effects of CS misuse and abuse are global. However, since evidence supports
the notion that education increases patients’ knowledge of storage, disposal, and use, (McCarthy
et al., 2015; McCauley et al., 2013; Rose et al., 2015) one could hypothesize that CS diversion,
related motor vehicle accidents, and misuse behaviors would be positively affected. Use of the
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CS AVS could increase patient knowledge, thereby reducing opioid overdose and related
problems.
Implementation of patient education is the first step to addressing patients’ knowledge of
their controlled substances. The Health Belief Model is based on the understanding that a person
will take health related action if they believe a negative outcome can be avoided, that a
recommendation can help, and that they can successfully implement the recommendation
(Rosenstock, 1974). In applying the Health Belief Model to this project, one could argue that
providing education to patients about how to safely use their prescribed CS would increase
knowledge and awareness of potential negative outcomes, thus encouraging the patient to
implement recommendations.
Abuse of CS’s has increased nationally and specifically in the state of Kentucky.
Interventions must be implemented to curb this problem. Integrating a controlled substance AVS
compliments the CDC guideline by reiterating safety concerns discussed by the provider and
could theoretically reduce morbidity and mortality.
The purpose of this project is to evaluate medication knowledge of a sample of adult
primary care patients with chronic non-cancer pain currently prescribed a CS who have and have
not received the CS AVS. The overall goal is to evaluate the effect of the AVS on patients’
knowledge of controlled substances by meeting the following objectives:
Objective 1: Assess whether patients received the CS AVS
Objective 2: Assess differences in pain management knowledge between those who received the
AVS and those who did not.
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Methods
This was a descriptive correlational design study to examine differences in pain
management knowledge between those who did and did not receive the AVS. The study included
patients that received care and a prescription for a controlled substance at a primary care office
for the management of chronic pain.
Setting and Sample
The study took place in two primary care offices located in Louisville, Kentucky
(Jefferson County). The primary care offices were chosen for inclusion in the study because they
are in the top five primary care offices in the healthcare system for prescribing CS. Both offices
are located within Louisville but in different residential areas. One office is connected to a
hospital and the other is located in a shopping center.
For this study, inclusion criteria were adult (>18 years of age) primary care patients with
chronic pain currently prescribed a controlled substance. The population for this study included
all genders and ethnicities. Exclusion criteria were patients chronically prescribed a controlled
substance for cancerous pain, pediatric patients (<18 years of age) and patients that were
prescribed a controlled substance for an acute diagnosis (defined by the CDC as three months or
less) (2016). Development of exclusion criteria was due to differences in pain management
goals in these populations. Additionally, any new patients presenting to establish care were
excluded so as not to add to the paperwork that needs to be filled out on the first visit. The
addition of another document to complete when establishing care was seen as burdensome. New
patients were also excluded because they did not have an established relationship with the office.
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Measures
Knowledge of the patient’s pain medication was measured via written survey. Patients
were surveyed from August 2018 to September 2018. To meet objective one, the survey
included a question asking if the patient had ever received any information/education on the
AVS or discharge paperwork about the management of their controlled substances. They were
given the choice of yes, no or unsure.
To meet objective two, data was collected using the pain medication knowledge survey,
which was developed for this project from two sources. The Patient Pain Questionnaire (PPQ) is
a 16 question ordinal scale developed in 1987 to evaluate the knowledge and experience of basic
chronic cancer pain management, and has been tested and proven reliable and valid (Ferrell,
Rhiner & Rivera, 2003). The PPQ is divided into subscales: a nine-question knowledge section
and a seven-question experience section. The nine-item questionnaire gave the patients the
option to agree or disagree with the statement on an ordinal scale (0 = agree to 5 = strongly
disagree).
For the purposes of this study, only some of the nine-question knowledge portion were
utilized and adapted for use in chronic pain, and included all questions related to noncancerous
pain. Additional questions added related to the recommendations of the 2016 CDC Guideline for
Prescribing Opioids for Chronic Pain. The survey included ten questions in total, some from the
PPQ, some derived from the CDC Guideline for Prescribing Opioids for Chronic Pain
recommendations and one asking if they recalled receiving the AVS education.
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Procedures
Participants were recruited by reviewing daily patient schedules at both offices. The
primary investigator (PI) reviewed both primary care offices’ patient schedules weekly to
determine if the patient met the above inclusion criteria. For those patients meeting inclusion
criteria, the PI reviewed the medicine list for any controlled substances. If a controlled substance
was listed on the patient’s medication administration record (MAR), the PI then evaluated the
diagnosis requiring treatment and how long the medication had been prescribed to ensure the
inclusion criteria of chronic (>3months) noncancerous pain was met.
Once the patient was determined to meet inclusion criteria, the PI collected demographic
data (age/sex/race). Demographic data was collected on all patients meeting inclusion criteria
versus just those that chose to participate so patients could remain de-identified. The daily list of
eligible patients was provided to the front office staff. When the patient presented to the office
for their scheduled appointment, the office staff provided standard registration care and then
presented the cover letter with the attached survey to the patient. If the patient chose to be
included, they completed the survey and returned it to the office staff. The office staff placed the
survey in a locked box and the PI picked up surveys weekly. If the patient did not want to
participate for any reason, the survey could simply be thrown away. The survey was completely
anonymous and had no patient identifiers on it. The PI had no way to know how many surveys
were distributed by the front desk staff. The inability to document this number was due to IRB
restrictions. Prior to the start of the study, approval from the University of Kentucky
Institutional Review Board (IRB) and the Office of Research and Administration at the
healthcare system was obtained.
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Data Analysis
All analysis was conducted in SPSS Version 22 and charts were constructed in Microsoft
Word and Excel. Descriptive statistics were used to describe the demographic data of the 317
eligible patients including frequencies, standard deviations and means. A two sample T-test was
utilized to compare the survey responses between the two groups, those that received the survey
versus those that did not.
Results
Between the two offices, a total of 317 patients met inclusion criteria, and therefore their
names were given to the front desk staff to offer the survey. There were 47 surveys returned, ten
of which were unusable because they were filled out incorrectly or incompletely, resulting in 37
useable surveys. The response rate was 12%.
Demographic data was collected on the 317 eligible patients from both offices and
combined. The mean age was 61 years (SD=11.956), with the youngest patient 29 years old and
the oldest 95 years old. Fifty eight percent (n=184) of the sample were female. Eighty four
percent (n=265) were Caucasian, African Americans were 15% (n=48) and other ethnicities were
1% (n=4). Demographic data of the sample can be seen in Table 1.
Of the survey responses, 49% said they received the education and 51% answered they
did not recall ever receiving any education about their controlled substances (objective one).
When evaluating if there was a difference in knowledge between the two groups (objective two),
the data showed no statistical significance between those that received the education and those
that did not. Data on each question response is illustrated in Table 2.
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Interestingly, there were some themes noted on specific questions. Of both the patients
that received the education and those that did not, most strongly agreed with question six (I plan
to dispose of extra, unused and expired medication) and question seven (I take medication as
directed and prescribed). Alternatively, both groups most strongly disagreed with questions one
(treatments other than medication can be effective i.e. alternative therapies), four (side effects
include drowsiness, constipation and nausea), and question five (pain medication can affect
breathing).
Discussion
Demographics
The sample demographics were obtained on all eligible patients via chart review and
were similar at both offices. Examination of the sample showed that 58% were female, which is
consistent with previous literature proving women utilize healthcare more often than men
(Bertakis, 2000). Additionally, the sample was heavily Caucasian (84%). The remaining part of
the sample was African American (15%) and 1% was considered other. The race and sex
demographics of the sample are consistent with those in Jefferson County (US Census Bureau,
2017).
In this study both objectives were met by use of a survey. Patients were offered a tenquestion survey by the primary care office to evaluate if the education was received (objective
one) and if there was a difference in knowledge between those that received the education versus
those that did not (objective two).
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Objective I
Of the sample, 49% reported they received the written education in the after visit summary. The
other 51% percent of the sample reported they did not receive the education or were unsure.
Interestingly, when the AVS was implemented into the electronic medical record it was
formatted to automatically attach when any controlled CS was prescribed. The implementation
of the AVS was in February of 2018 and patients were surveyed in August and September of
2018. Because their prescribing providers see chronic CS patients every three months, all the
patients should have received the education.
The fact that only 49% reported receiving the education, yet the entire sample should
have received the education on their AVS, may speak to the avenue that the education was
delivered. Approximately 51% of patients were unaware, did not see, or did not understand the
education. The literature indicates that written education, audio/video tapes and lectures have a
positive effect on patient knowledge and have proven to be more effective than solitary
discussion or verbal education (Friedman, Cosby, Hatton-Bauer, and Turnbull, 2010; Trevena,
L., Davey, H., Barratt, A., Butow, P., & Caldwell, P., 2006, Theis and Johnson, 1995; Dunn, K.,
Yepez-Laubach, C., Nuzzo, P., Fingerhood, M., Kelly, A., Berman, S., and Bigelow, G. 2017).
Pervious studies implementing written and computerized CS education found increases in
knowledge for those participating (Dunn et al., 2017 & Rose, 2015). Employing multiple
educational strategies and addressing patients’ specific needs resulted in better patient outcomes
(Friedman et al., 2010, Theis, 1995; Jeste, Dunn, Folsom, and Zisook, 2006).
Additionally when utilizing written patient education, consideration for literacy levels
can increase knowledge (Friedman et al., 2010). Structured and tailored education with the
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addition of illustrations aids understanding (Trevena et al., 2006). The AVS was reviewed and
edited by a literacy expert within the healthcare system to ensure it was readable at a 5th grade
level, but no illustrations were included.
Objective II
When evaluating the knowledge of the sample, there was no significant difference
between the two groups, and overall the group was knowledgeable about their controlled
medications. This raises the question of whether the sample received education from another
source. The CDC guideline outlines discussion points that providers must have with patients at
the start of and periodically during treatment so the sample could have received education from
the prescribing provider (2016). The literature indicates written education that is summarized
verbally can increase effectiveness and retention of knowledge (Friedman et al., 2010; Trevena,
2006). This study did not evaluate if the patient received additional controlled substance
education, so provider education or other means could be confounding variables effecting patient
knowledge.
The purpose of the education was not to be a resolution to the opioid epidemic, but rather
a measure to increase patient safety in hopes to prevent further misuse, addiction, and diversion
of CS. Because prescription opioids are often diverted for improper use and can be a bridge to
less expensive illicit drugs such as heroin, safe use of controlled substances is of great
importance (SAMHSA, 2016). Additionally, research shows that for each dollar invested in
prevention, a savings of up to $10 in treatment for alcohol or other substance abuse can be seen
(National Institute of Drug Abuse [NIDA], 2003). Although there was not great significance in
knowledge differences between the two groups in this study, the Health Belief Model argues that
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repeated and continued education on the topic can only help reinforce the awareness of potential
negative outcomes, thus encouraging the patient to implement recommendations (Rosenstock,
1974).
Limitations
A limitation to this study included the small sample size. Two of the top five prescribing
offices within this healthcare system were included in this study, but the results could be more
generalizable if all five offices were included. The feasibility of this would be difficult for a sole
investigator due to the time needed to review charts for eligible patients.
An additional limitation was the low response rate of 15%. The PI presented a list of
eligible patients to the front desk staff daily but it was not routine for front desk staff to offer
surveys to specific patients, making it easily forgotten on busy days. Additionally, some patients
declined to answer the survey, which was expected due to the sensitive nature of the topic. In
future studies with a similar design, adding an electric flag to eligible patient charts in the EMR
may be a helpful way to remind the front desk to offer the survey.
The fact that the survey was adapted and designed for this study versus a validated survey
also presents a limitation. There was no available validated survey to meet the needs of this
project. Implications for future research would be the development of a validated survey to
evaluate controlled substance knowledge of patients that are chronically prescribed controlled
substances for noncancerous pain.
A final limitation was that responses were self-reported. It should be considered that
patients might have answered questions differently out of concern for loss of therapy. The
question, ‘I take my medication as prescribed by my provider,’ was the most strongly agreed
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response. Was this accurate or were patients responding with what they thought the provider
would want to hear? This limitation was considered when developing the design of the study.
The survey was anonymous and no demographic information was asked on the survey with the
hopes that patients would feel more confortable to respond truthfully.
Research Implications
The demographics of this study were not diverse. The sample was more heavily female
and Caucasian. If future research is done on the subject, including a larger sample from different
areas of Jefferson County would be helpful to greater understand the educational needs of the
area.
There was no significant difference in knowledge between the two groups and they were
generally knowledgeable about their controlled substances. This raises the question of what are
the most effective educational methods for patients to learn. Although research has been done on
the effectiveness of educational methods it would be interesting to evaluate what methods
patients within this healthcare system find most helpful. Because this sample was
knowledgeable about their controlled medications, it would be relevant to research where
patients received their knowledge and what methods they found helpful to obtain this knowledge.
Interestingly, this sample of patients did not feel that use of alternate therapies were
effective in the relief of their chronic pain. Previous literature on alternate therapies had mixed
findings. Systematic reviews of interventions for chronic pain, such as Pilates, Tai Chi,
acupuncture, and herbal medicines, found a short term clinically relevant effect on pain but had
difficulty providing any strong recommendations due to the lack of studies with adequate sample
sizes free of bias (Rubinstein, S., Middelkoop, M., Kuijpers, T., Ostelo, R., Verhagen, A., Boer,
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M., Koes, B. & Tulder, M., 2010; Wells, C., Kolt, G., Marshall, P., Hill, B. & Bialocerkowski,
A., 2014). This may explain why this patient population found alternative therapies unhelpful
when treating their chronic pain.
Alternatively, to the above findings there were some positive results in regard to
psychological interventions in the treatment of chronic pain. Interventions such as mindfulness
and cognitive behavioral therapy have seen reductions in healthcare utilization, patient reported
pain, and self care techniques to manage pain, but further research is needed on the most
efficacious dose and delivery methods of these modalities (Pike, A., Hearn, L. & Williams, A.,
2016; Berman, R., Iris, M., Bode, R. & Drengerberg, C., 2009; Knoerl, R., Lavorie Smith, E. &
Weisberg, J., 2016; Wetherell, J., Petkus, A., Alonso-Fernandez, M., Bower, E., Steiner, A. &
Afari, N., 2015).
Practice Implications
Although all of the patients in this study should have received the education, only half of
the sample recalled receiving the AVS. Written instruction allows the patient to decide whether
or not to read the education provided. This presents an opportunity for providers to highlight and
directly draw attention to the AVS so patients are aware of the education. Adding additional
verbal instruction was found to be more effective than just one teaching method (Friedman et al.,
2010; Trevena et al., 2006). Furthermore, the research supports access to other forms of
education in addition to the AVS to increase patient knowledge (Friedman et al., 2010; Trevena
et al., 2006; Theis at el., 1995; Jest at el., 2006; Dunn at el., 2017). There is an opportunity to
help implement additional educational resources on CS for patients.
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Side effects were a knowledge deficit for both groups. It is possible that this sample of
chronic pain patients were tolerant or complacent to the medication’s side effects such as nausea,
constipation and drowsiness. Another consideration is that a clear knowledge deficit is present.
A practice implication for healthcare providers would be to focus on this area when educating
patients about CS.
Conclusion
  

Opioid addiction, misuse, and diversion continue to be a health concern for the state of

Kentucky and the nation. Preventative measures and patient education must be provided when
controlled substances are prescribed. This study demonstrated no significant difference in
patient knowledge of controlled substances between those that received the after visit summary
education and those that did not. The literature supports the use of written patient education but
notes there is an increased effectiveness with more than one form of education. Further
implementation of resources for patients to learn about controlled substances and research on the
topic is needed.
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Appendix A
Copy of After Visit Summary
Management of Controlled Substance Patient Education
What You Need To Know:
You have been given a controlled substance prescription. A controlled substance is a medicine that is
monitored or regulated by the government because they can be improperly used or abused. People can
become addicted to these medicines. Controlled substance medicines are often used for:
·
Pain
·
Sleeping problems
·
Worry
·
Anxiety
·
Cough or colds
There are risks to taking these types of medicines including the possibility of:
·
Physical drug dependence – You may not be able to stop using the medications. When you try to
stop, you may have withdrawal symptoms and strong cravings for the medications.
·
Drug tolerance - When you need to use more medications, or use them more often, to get the
effects you want.
·
Addiction – When a person uses the controlled substance to get high instead of using them to
control the medical problem. You will have the urge to continue using the medications even when you
know the risks.
·
Drug overdose - When a person takes more medications than their body can handle. This may be a
small amount or a large amount of medication.
The risks are greatest when the medicine is taken for long periods of time or not taken correctly.
The goal of treatment is to improve pain, function and help you feel better. These medications will not
completely relieve all your pain or cure your medical problem.
It is important to discuss with your health care provider the goal of treatment with these medicines. You
need to have a plan to stop the medicine as soon as your medical problem is better.
Safety Measures:
These medicines should only be taken as directed by your healthcare provider.
Keep medicines locked up and out of reach of children.
Do not take medication in front of children as they are likely to mimic your behavior.
Do not drink alcohol while taking these medicines. Drinking alcohol with a controlled substance
can cause your breathing to slow or stop.
Do not drive while taking these medicines. You can become drowsy and fall asleep.
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Taking a controlled substance while pregnant can be harmful to your baby. Let your provider
know you are pregnant immediately to discuss possible risks.
When medicines are no longer needed, you should safely dispose of the medicines. Studies have
shown that many people who become addicted to these medications used someone else’s medication
found in their home. In Louisville, medication drop boxes are located at:
Jefferson County Sheriff’s Office
531 Court Place
Louisville, KY
(502) 574-5400
Monday-Friday 8am-4pm
St Matthew’s Police Department
3940 Grandview Ave
Louisville, KY
(502) 893-9000
Monday- Friday 8am-4pm
Find other locations at:
-Kentucky Drug Disposal Location Look Up https://odcp.ky.gov/Pages/Prescription-Drug-DisposalLocations.aspx
-DEA Drug Disposal Location Look
Up https://apps.deadiversion.usdoj.gov/pubdispsearch/spring/main?execution=e1s1
-Walgreen Pharmacies – Some Walgreens have a safe disposal program. Look up the closest location
at www.walgreens.com/storelocator/find.jsp?RxDisposal=true<http://www.walgreens.com/storelocator/fi
nd.jsp?RxDisposal=true>
If you are unable to access these locations, there are ways to safely throw away medications at home.
Some medicines can be flushed to prevent unintended access by others.
-Refer to the FDA website to check your specific medicine www.fda.gov<http://www.fda.gov/>
-The Kentucky Poison Control Center (www.kypoisoncontrol.com<http://www.kypoisoncontrol.com/>)
can answer questions. Medical staff are available are available through the hotline 24 hours a day at 1800-222-1222.
Medication Side Effects:
Breathing too slow or stopped
Drowsiness/tiredness
Dizziness
Constipation
Nausea and vomiting
Itching
Dry mouth
It is important to talk with your healthcare provider about any side effects you experience.
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CALL 911 or have a family member call if:
Breathing is slower than normal
You cannot be awakened
You have a seizure
Talk with your healthcare provider about other ways to manage pain:
Apply heat on the area of pain 20-30 minutes every 2 hours as directed to help decrease pain and
muscle spasms.
Consider other Medications. Talk to your healthcare provider about different medication options.
Go to physical therapy as directed. Physical therapist help teach you exercises to decrease pain
and improve your quality of life.
Exercise for 30 minutes, 3 times a week. Regular physical activity can decrease pain and improve
movement and strength.
Get enough sleep. Create a bedtime routine. Go to sleep and wake up at the same time every
day. Avoid afternoon caffeine.
Talk with a counselor or therapist. Untreated depression or anxiety can worsen pain symptoms. A
type of counseling called cognitive behavioral therapy (CBT) can help your pain by changing the way you
think about it. CBT can also improve your mood, sleep, and the way you move.
Follow Up With Your Healthcare Provider:
You will need to go to your provider often when taking these medicines. The provider will need to
check to see how the medicine is working. Make sure you go to all appointments.
Call your provider if:
o Your medical problem has changed
o You are having side effects that are concerning to you. Some of the side effects can be helped by
changing the dose of the medicine.
o You have any questions or concerns
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Appendix B
Copy of Patient Survey
Controlled  Medication  Survey  
Directions:  There  are  nine  short  questions.    Read  the  question  and  decide  if  you  agree  or  disagree  with  
the  statement.    Then  circle  a  number  to  indicate  the  degree  to  which  you  agree  or  disagree.    All  questions  
are  scored  on  a  0-‐5  scale.    0  is  you  agree  and  5  meaning  you  disagree.  
Questions  
1.    Treatments  other  than  medications  (such  as  massage,  heat  and  relaxation)  can  be  effective  for  
relieving  pain.  
Agree        0        1        2        3        4        5        Disagree  
2.    There  is  a  risk  of  dependence  and  addiction  when  taking  controlled  substances.  
Agree        0        1        2        3        4        5        Disagree  
3.  The  goal  of  treatment  is  to  improve  pain  and  function  but  complete  relief  of  pain  may  not  always  
be  likely.  
Agree        0        1        2        3        4        5        Disagree  
4.    Side  effects  of  my  medication  include  drowsiness,  constipation,  and  nausea.  
Agree        0        1        2        3        4        5        Disagree  
5.    Pain  medication  can  be  dangerous  and  effect  breathing.  
Agree        0        1        2        3        4        5        Disagree  
6.    I  plan  to  dispose  of  extra,  unused  or  expired  medications  at  a  disposal  sight.  
Agree        0        1        2        3        4        5        Disagree  
7.    I  take  my  medication  as  directed  and  prescribed  by  my  healthcare  provider.  
Agree        0        1        2        3        4        5        Disagree  
  
8.    I  keep  my  medications  locked  up.  
Agree        0        1        2        3        4        5        Disagree  
9.    I  do  not  drive  while  taking  my  controlled  substance.  
21  
  

  
Agree        0        1        2        3        4        5        Disagree  
10.    Have  you  ever  had  any  information/education  on  your  After  Visit  Summary  or  Discharge  
paperwork  about  your  controlled  medication?  
YES______    NO_______  UNSURE________  
  You  have  completed  the  entire  survey.    Thank  you  greatly  for  your  time  and  thought.    All  these  responses  
will  be  kept  completely  confidential.    If  you  have  any  questions  at  a  later  time  you  have  my  contact  
information  and  feel  welcome  to  call  or  email  me.  
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Table 1
Demographic characteristics of the study sample (N = 317)
Characteristic

Mean (SD) or n (%)

Age

61 (SD = 11.956)

Gender
Male

133 (42%)

Female

184 (58%)

Race
White

265 (84%)

Black

48 (15%)

Other

4 (1%)

Office
Site 1

107 (34%)

Site 2

210 (66%)
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Table 2
Survey Responses
Comparison of Knowledge for Those That Received Education vs. Those That Did Not Receive
Education  
Received Education
(n=18)

Did not Receive
Education

p

(n=19)

Mean (SD)

Mean (SD)
1. Treatments other than
medication can be
effective for relieving
pain

3.11 (1.079)

2.42 (1.465)

.11

2. There is a risk of
dependence and
addiction when taking
controlled substances

2.11 (1.937)

2.00 (1.667)

.85

3. The goal of treatment
is to improve pain and
function but complete
relief of pain may not
always be likely

1.39 (1.539)

1.21 (1.398)

.71

4. Side effects of my
medication include
drowsiness,
constipation, and nausea

3.12 (1.799)

2.56 (1.790)

.36

5. Pain medication can
be dangerous and effect
breathing

3.06 (1.519)

2.74 (1.790)

.57

6. I plan to dispose of
extra, unused or expired
medications at a
disposal site

.94 (1.697)

.67 (1.029)

.56

7. A take my
medications as directed
and prescribed by my
healthcare provider

.71 (1.649)

.21 (.419)

.24
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8. I keep my
medications locked up

1.39 (1.883)

1.16 (1.385)

.67

9. I do not drive while
taking my controlled
substance

1.94 (2.155)

1.21 (1.357)

.22
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Figure 1
Figure 1: Rate of Opioid-Related Overdose Deaths in Kentucky

(National Institute on Drug Abuse, 2018)
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